Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

BACKGROUND: Cardiac arrhythmias are associated with poorer outcomes in patients with heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies have shown inconsistent conclusions regarding the association between sodium-glucose cotransporter 2 inhibitors (SGLT2i)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hang-Long, Lip, Gregory Y. H., Feng, Qi, Fei, Yue, Tse, Yi-Kei, Wu, Mei-zhen, Ren, Qing-wen, Tse, Hung-Fat, Cheung, Bernard-M. Y., Yiu, Kai-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106208/
https://www.ncbi.nlm.nih.gov/pubmed/33962654
http://dx.doi.org/10.1186/s12933-021-01293-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106208/
https://www.ncbi.nlm.nih.gov/pubmed/33962654
http://dx.doi.org/10.1186/s12933-021-01293-8

Ejemplares similares